Security key
17331Y109
CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR)
CUSIP: 17331Y109
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Shares, $0.0001 par value per share
- Total 13F shares
- 105,008
- Total 13F value
- $97,657
- Share change
- -95,876
- SEC-reported price per share
- $0.93
- Number of holders
- 6
- Value change
- -$115,519
- Number of buys
- 2
- Number of sells
- 6
- Shares outstanding
- 93,027,627
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
6
Top holders
6
CTOR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
CITIUS ONCOLOGY, INC. SEC filings
CITIUS ONCOLOGY, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 17331Y109
Recent filing periods:
Ownership snapshot
Top reported holders of CTOR - CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HRT FINANCIAL LP
Disclosed value leader
HRT FINANCIAL LP
Comparable rows
11/14
Latest evidence
31 Dec 2024
13F
3/4/5
Lead comparable stake: 0.07%
3 rows are not safely comparable across share classes.
Showing 1-6 of 14 holder rows.
Quick read
HRT FINANCIAL LP leads the comparable SEC ownership view at 0.07%.
11 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HRT FINANCIAL LP's linked filing trail.
Comparable ownership
Top 5
HRT FINANCIAL LP
0.07%
UBS Group AG
0.03%
CITADEL ADVISORS LLC
0.02%
IFP Advisors, Inc
0.02%
XTX Topco Ltd
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HRT FINANCIAL LP |
13F
Company
|
0.07%
|
$78,000
68,543 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
0.03%
|
$28,526
24,805 shares
|
— | 31 Dec 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.02%
|
$26,104
22,699 shares
|
— | 31 Dec 2024 |
| IFP Advisors, Inc |
13F
Company
|
0.02%
|
$25,547
22,215 shares
|
— | 31 Dec 2024 |
| XTX Topco Ltd |
13F
Company
|
0.02%
|
$24,259
21,095 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.01%
|
$14,548
12,651 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
105,008
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
11
Q1 2025 holders
6
Holder diff
-5
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend